CBOE vs CME: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

CME is the larger of the two ($111.76B market cap): the incumbent the market prices for continued execution (23.56x forward earnings, beta 0.18). CBOE is the smaller challenger ($37.92B), priced similarly on forward earnings (23.37x): more room to run, but more to prove. If the story you believe is CBOE's (Proprietary volatility and index-options franchise), CBOE is the more direct way to own it; if it is CME's (Record trading volumes), CME is.

CBOE vs CME: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricCBOECMEWhat it tells you
Market cap$37.92B$111.76BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E23.3723.56Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E25.8725.59Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.360.18Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range89% of range85% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book6.404.20How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Before you buy: how CBOE and CME affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CBOE and CME share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CBOE and CME exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Cboe Global Markets (CBOE) do?

Cboe Global Markets operates a family of exchanges spanning options, North American equities, European and Asia-Pacific markets, futures, and global FX, and it earns money primarily from transaction fees, market data, and access services. Its crown jewel is the proprietary volatility franchise: the VIX index, VIX futures and options, and SPX index options are exclusively listed on Cboe venues, giving it a durable niche that rivals cannot easily replicate. The Data Vantage segment (market data and analytics) adds a recurring, subscription-like revenue stream on top of the more volume-sensitive transaction business.

Full CBOE guide

What does CME Group (CME) do?

CME Group operates the largest futures and options marketplace in the world, spanning six asset classes: interest rates, equity indexes, energy, agricultural commodities, metals and foreign exchange. It earns money mainly from clearing and transaction fees charged on every contract traded and cleared, plus market-data and information-services revenue, and it benefits from owning both the exchange and the clearinghouse that guarantees trades. Volumes rise with hedging demand and market volatility, which is why record average daily volume has been the main engine of recent results.

Full CME guide

CBOE vs CME: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • CBOE drivers: Proprietary volatility and index-options franchise; Recurring Data Vantage revenue.
  • CME drivers: Record trading volumes; Interest-rate and volatility franchise.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Cboe's transaction revenue is tied to trading volumes and market volatility, so a prolonged calm, low-volume market environment can pressure its most profitable options and VIX products. For CME, revenue is cyclical and tied to trading volumes, so a prolonged low-volatility environment can depress activity and fees.

CBOE or CME: which should you pick?

With growth, valuation and volatility this close (or not yet reported for one side), the drivers above are what separate CBOE from CME. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CBOE and CME guides.

CBOE vs CME: the full fundamentals

CBOE. As of November 20, 2026, Cboe trades near $364, about 26 times trailing and 23 times forward earnings, a higher multiple than in October because the share price rose faster than estimates. Third-quarter adjusted EPS of $3.63 beat the $3.43 consensus. Consensus expects EPS of about $14.50 for 2026 and $15.55 for 2027, so the valuation now assumes elevated options activity persists while growth slows.

CME. CME has kept rerating upward, gaining ~12.6% in three months to ~$312 in November 2026, close to its 52-week high of ~$329, so the trailing P/E has moved to about 26 as third-quarter revenue growth returned to ~13%. Analysts' mean target of ~$318 sits just above the share price, with a buy consensus across sixteen analysts. The regular dividend alone yields ~1.7%; the variable year-end dividend, declared each December, adds to that and makes the headline blended yield materially higher.

Headline figures (approximate, November 2026): CBOE shows total revenue (ttm) ~$5.3B (includes pass-through fees), net revenue (q3 2026) ~$712M (+~19% YoY), q3 2026 adjusted eps $3.63 vs ~$3.43 est., margins (ttm) ~36% operating, ~28% net; CME shows revenue (ttm) ~$6.96B (FY2025 ~$6.52B); Q3 2026 ~$1.74B, +~13% y/y, net income (ttm) ~$4.40B, profit margin ~63%, operating margin ~66%, eps (ttm / 2026 / 2027 est.) ~$12.20 trailing; ~$12.40 consensus for 2026; ~$13.25 for 2027.

The bottom line: CBOE vs CME

CBOE and CME are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined CBOE and CME exposure against your real portfolio. It is not an investment adviser.

Wondering how CBOE or CME fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Cboe Global Markets

Ask Walnut's AI anything about CBOE and see how it fits what you own.

FAQ

What is the difference between CBOE and CME?

+

Cboe Global Markets operates a family of exchanges spanning options, North American equities, European and Asia-Pacific markets, futures, and global FX, and it earns money primarily from transaction fees, market data, and access services. CME Group operates the largest futures and options marketplace in the world, spanning six asset classes: interest rates, equity indexes, energy, agricultural commodities, metals and foreign exchange. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is CBOE or CME the better stock?

+

Neither is universally better. CME is the larger incumbent; CBOE is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, CBOE or CME?

+

On forward P/E (as of November 2026), CBOE trades at 23.37x and CME at 23.56x, so CBOE is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both CBOE and CME?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of CBOE vs CME?

+

CBOE: Cboe's transaction revenue is tied to trading volumes and market volatility, so a prolonged calm, low-volume market environment can pressure its most profitable options and VIX products. Emerging competitors and new instruments, including crypto perpetual-futures venues like Kalshi that regulators have begun to approve, could siphon derivatives flow over time, a risk analysts flag as most acute for Cboe among the major exchange operators. Regulatory changes affecting market structure, fees, or market-data pricing represent an ongoing overhang for all exchanges. The premium valuation leaves limited room for error if volume growth normalizes. Concentration in a handful of index and volatility products means any competitive or structural erosion there would matter disproportionately. Two newer points: analysts expect EPS growth to slow from about 36% in 2026 to about 7% in 2027 as comparisons get tougher, and after a 47% gain this year the consensus rating is Hold with a mean target near $360, slightly below the November 20, 2026 price. The KPI and other binary contracts are untested and launch fee-free through 2026, so they add regulatory and reputational exposure before they add revenue. CME: Revenue is cyclical and tied to trading volumes, so a prolonged low-volatility environment can depress activity and fees. Competition is intensifying: FMX targets U.S. Treasury and SOFR futures with LCH clearing, ICE dominates Brent energy, and Cboe leans on VIX and options flow. A newer threat is regulated perpetual futures from crypto venues such as Coinbase and Kalshi, which the market fears could eventually breach the regulatory moat protecting high-margin retail products like 0DTE options. The stock also trades at a premium exchange multiple, so any volume slowdown or fee compression can weigh on the shares. Growth slowed sharply in the second quarter of 2026, with revenue up less than 1% year over year, before recovering to ~13% in the third. Consensus calls for ~11% EPS growth in 2026 and ~7% in 2027, which leaves a ~24x forward multiple with limited room for a volume slump. Chairman and CEO Terry Duffy sold 27,000 directly held shares (about $8.4 million) on 18 November 2026 near a record price, cutting his direct stake by about 43% to 35,442 shares, a sale the market will read alongside the stock's run.

Related comparisons

Browse all stock comparisons.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell CBOE or CME; figures are approximate and dated (as of November 2026). Verify current data before investing.